186 related articles for article (PubMed ID: 31401981)
1. Overcoming multidrug resistance by activating unfolded protein response of the endoplasmic reticulum in cisplatin-resistant A2780/CisR ovarian cancer cells.
Jung E; Koh D; Lim Y; Shin SY; Lee YH
BMB Rep; 2020 Feb; 53(2):88-93. PubMed ID: 31401981
[TBL] [Abstract][Full Text] [Related]
2. Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway.
Bahar E; Kim JY; Kim DC; Kim HS; Yoon H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920140
[TBL] [Abstract][Full Text] [Related]
3. Low expression of FXYD5 reverses the cisplatin resistance of epithelial ovarian cancer cells.
Liu YK; Jia YJ; Liu SH; Shi HJ; Ma J
Histol Histopathol; 2021 May; 36(5):535-545. PubMed ID: 33570156
[TBL] [Abstract][Full Text] [Related]
4. A synthetic chalcone, 2'-hydroxy-2,3,5'-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in breast cancer cells.
Lee DH; Jung Jung Y; Koh D; Lim Y; Lee YH; Shin SY
Cancer Lett; 2016 Mar; 372(1):1-9. PubMed ID: 26742460
[TBL] [Abstract][Full Text] [Related]
5. The synthetic chalcone derivative 2-hydroxy-3',5,5'-trimethoxychalcone induces unfolded protein response-mediated apoptosis in A549 lung cancer cells.
Gil HN; Koh D; Lim Y; Lee YH; Shin SY
Bioorg Med Chem Lett; 2018 Sep; 28(17):2969-2975. PubMed ID: 30017320
[TBL] [Abstract][Full Text] [Related]
6. G-Protein-Coupled Receptor 120 Mediates DHA-Induced Apoptosis by Regulating IP3R, ROS and, ER Stress Levels in Cisplatin-Resistant Cancer Cells.
Shin JI; Jeon YJ; Lee S; Lee YG; Kim JB; Lee K
Mol Cells; 2019 Mar; 42(3):252-261. PubMed ID: 30764601
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
[TBL] [Abstract][Full Text] [Related]
8. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F
Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
[TBL] [Abstract][Full Text] [Related]
11. Confirming whether novel rhein derivative 4a induces paraptosis-like cell death by endoplasmic reticulum stress in ovarian cancer cells.
Pang HF; Li XX; Zhao YH; Kang JK; Li JY; Tian W; Wang CM; Hou HX; Li DR
Eur J Pharmacol; 2020 Nov; 886():173526. PubMed ID: 32890460
[TBL] [Abstract][Full Text] [Related]
12. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer cells via the reactive oxygen species-mediated unfolded protein response with a novel synthetic polyphenol conjugate.
Shin SY; Lee JM; Lee MS; Koh D; Jung H; Lim Y; Lee YH
Clin Cancer Res; 2014 Aug; 20(16):4302-13. PubMed ID: 24938523
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis.
Xu Y; Wang C; Su J; Xie Q; Ma L; Zeng L; Yu Y; Liu S; Li S; Li Z; Sun L
Oncol Rep; 2015 Dec; 34(6):3051-60. PubMed ID: 26398138
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosis.
Fujimoto A; Kawana K; Taguchi A; Adachi K; Sato M; Nakamura H; Ogishima J; Yoshida M; Inoue T; Nishida H; Tomio K; Yamashita A; Matsumoto Y; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Osuga Y; Fujii T
Oncotarget; 2016 Aug; 7(32):51854-51864. PubMed ID: 27322083
[TBL] [Abstract][Full Text] [Related]
16. Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression.
Bahar E; Kim JY; Kim HS; Yoon H
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076245
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2.
Gallerne C; Prola A; Lemaire C
Biochim Biophys Acta; 2013 Jun; 1833(6):1356-66. PubMed ID: 23485394
[TBL] [Abstract][Full Text] [Related]
18. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
19. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-proteasome System Is a Promising Target for Killing Cisplatin-resistant Bladder Cancer Cells.
Okubo K; Isono M; Asano T; REßING N; Schulz WA; Hansen FK; Sato A
Anticancer Res; 2021 Jun; 41(6):2901-2912. PubMed ID: 34083281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
